abstract |
The present invention relates to pharmaceutical compositions for treating interleukin-6 (IL-6) related diseases, including interleukin-6 antagonists (IL-6 antagonists) and immunosuppressants. The IL-6 antagonist is preferably an antibody against the interleukin-6 receptor (IL-6R). |